XLXiaorong Lv

Xiaorong Lv

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiaorong Lv has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Fang Nie

    Ultrasound Medicine Center, Lanzhou University Second Hospital, Lanzhou, China

    3 shared publications
  • Ran Zheng

    Ultrasound Medical Center, The Second Hospital of Lanzhou University, Lanzhou, China

    2 shared publications
  • Rong Yang

    Ultrasound Medical Center, The Second Hospital of Lanzhou University, Lanzhou, China

    2 shared publications
  • Yuanqing Zhang

    Ultrasound Medical Center, The Second Hospital of Lanzhou University, Lanzhou, China

    2 shared publications
  • Chi Zhang

    Ultrasound Medical Center, The Second Hospital of Lanzhou University Lanzhou China

    1 shared publication
  • Guo Chen

    Ultrasound Medical Center, The Second Hospital of Lanzhou University Lanzhou China

    1 shared publication

Latest Publications

  • Open Access

    A Non-Invasive Integrated Model for Accurate Preoperative Identification of the Aggressive Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma: A Single-Center Retrospective Study

    by Yuanqing Zhang, Yang He, Yifei Chen, Xiaorong Lv, Rong Yang, Guo Chen, Fang Nie

    Objective: The objective of this study was to develop and validate a predictive model for MTM-HCC by integrating preoperative ultrasound (US) and contrast-enhanced ultrasound (CEUS) features with relevant clinical characteristics. Methods: This retrospective study analyzed data from patients with histopathologically confirmed hepatocellular carcinoma who underwent preoperative CEUS examination at the Ultrasound Department of the Lanzhou University Second Hospital between December 2021 and March 2025. The study cohort comprised 45 patients diagnosed with MTM-HCC and 194 patients with non-MTM-HCC. Ultrasound and CEUS images were independently reviewed by two senior abdominal radiologists with extensive experience in hepatic imaging, ensuring objective feature assessment. Clinical variables and imaging characteristics were systematically compared between the two groups to identify distinguishing patterns. To evaluate the associations among clinical data, ultrasound-derived features, and MTM-HCC, univariate analyses were first performed, followed by multivariate logistic regression to construct and assess predictive models. Results: A total of 239 patients (mean age: 57.28 ± 9.60 years; 187 males and 52 females) were included in the analysis. Among them, 45 HCC patients (18.8%) were classified as MTM-HCC. Multivariate analysis identified four independent predictors: elevated alpha-fetoprotein (AFP ≥ 467 ng/mL) (OR = 8.5, 95% CI: 4.2–17.30; p < 0.001), presence of non-enhancing necrotic areas (OR = 5.92, 95% CI: 1.82–19.30, p = 0.003), intratumoral arteries (OR = 6.61, 95% CI: 2.28–19.22, p < 0.001), and peritumoral feeding arteries (OR = 3.13, 95% CI: 1.15–8.50, p = 0.025). Conclusions: An integrated prediction model that combines ultrasound imaging and clinical parameters offers a feasible, non-invasive approach for accurate preoperative identification of MTM-HCC.

  • Diagnostic analysis of contrast-enhanced ultrasound features in malignant partially cystic thyroid nodules

    by Guo Chen, Yanfang Wang, Guojuan Wang, Rong Yang, Ran Zheng, Yuanqing Zhang, Xiaorong Lv, Fang Nie

    Objective: Partially cystic thyroid nodules (PCTNs) are frequently underestimated in clinical practice and managed conservatively, potentially increasing the risk of cervical lymph node metastasis. This study aims to explore the contrast-enhanced ultrasound features associated with malignancy in PCTNs. Methods: This retrospective study included 94 PCTNs from 87 patients in the Second Hospital of Lanzhou University between January 2019 and December 2024. Conventional ultrasound, contrast-enhanced ultrasound (CEUS) features, and clinical data of the nodules were analyzed. Using pathological diagnosis as the gold standard, univariate and multivariate logistic regression analyses were conducted to identify independent predictors of malignancy in PCTNs. A predictive model was subsequently developed, and its diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis. Results: Centrifugal perfusion, an ill-defined enhancement boundary, faster washout, and the absence of a peripheral high-enhancement ring are independent predictors of malignant PCTNs. The resulting predictive model exhibited excellent diagnostic performance for PCTNs, with a sensitivity of 92.7%, a specificity of 92.5%, a Youden index of 0.852, and an AUC of 0.968. Conclusions: CEUS features are valuable in differentiating malignant nodules from benign PCTNs, improving physicians’ diagnostic confidence in distinguishing benign and malignant PCTNs, and assisting clinicians in clinical decision-making.

  • Hepatitis Virus Infection Predicts Heterogeneous Enhancement Patterns in Intrahepatic Cholangiocarcinoma on Contrast‐Enhanced Ultrasound: A Retrospective Radiological Cohort Study

    by Xiaorong Lv, Nan Wang, Chi Zhang, Ran Zheng, Yuanqing Zhang, Rong Yang, Guo Chen, Fang Nie

    Background: Chronic hepatitis is a significant risk factor for intrahepatic cholangiocarcinoma (ICC). Accurate identification of hepatitis‐associated ICC is critical for optimizing clinical management. This study aimed to differentiate hepatitis‐associated ICC from non‐hepatitis cases by integrating clinical and contrast‐enhanced ultrasound (CEUS) features. Methods: Using histopathology as the gold standard, a retrospective analysis was conducted on ICC patients who underwent CEUS at the Second Hospital of Lanzhou University (July 2020 to February 2025). Patients were stratified into hepatitis ( n = 36) and non‐hepatitis cirrhosis ( n = 82) groups. Baseline clinical and ultrasonographic characteristics were compared. Independent predictors of hepatitis‐associated ICC were identified via univariate and multivariate logistic regression, with diagnostic performance evaluated by receiver operating characteristic (ROC) curve analysis. Results: Compared to non‐hepatitis ICC (69.5%), hepatitis‐associated ICC (30.5%) showed significant differences in age ( p = 0.001), male predominance ( p = 0.001), elevated alpha‐fetoprotein (AFP, p = 0.002), carbohydrate antigen 19‐9 (CA19‐9, p = 0.010), absence of intrahepatic bile duct dilation ( p = 0.022), and homogeneous arterial‐phase enhancement on CEUS ( p < 0.001). Multivariate analysis identified male gender, advanced age, elevated AFP, CA19‐9 levels (27–100 U/mL), and homogeneous enhancement as independent predictors. The predictive model demonstrated an AUC of 0.8713 (95% CI: 0.7981–0.9445), with 82.9% sensitivity and 77.8% specificity. Conclusion: Conventional ultrasound and CEUS features provide additional diagnostic value for the non‐invasive identification of hepatitis‐associated ICC, enhancing preoperative risk stratification and therapeutic decision making.